Depo-Provera Brain Tumor Claims After 10 Years of Shots

Last updated: October 2026

“I got the shot every three months for ten years.” If that sentence describes you and you now have a meningioma diagnosis, you are not alone, and your questions are reasonable. Research links long-term use of the Depo-Provera shot to higher odds of meningioma, and thousands of women have filed Depo-Provera brain tumor claims. Your long history of use is often the heart of the claim. This guide also explains the terms in your medical reports and how Depo-Provera brain tumor claims are being reviewed under the court’s newest 2026 orders.

This post is written for long-term users. It does not share real patients’ stories or quotes. Instead, it walks through the questions many women in this situation ask, and what the research and court records actually say.

What ten years of shots adds up to

Depo-Provera is usually given every three months. Over ten years, that is about 40 injections, often at more than one clinic. For many women, it was simply part of life: easy, private and reliable.

That long history matters in two ways. First, the research focuses on prolonged use. Second, a claim usually needs proof of that use, which can be hard to piece together after many years.

What the research says about long-term use

The key study appeared in the BMJ in March 2024. French researchers compared more than 18,000 women who had surgery for an intracranial meningioma with more than 90,000 women who did not.

The study found:

• Using injectable medroxyprogesterone acetate, the drug in Depo-Provera, for a year or more was linked to about 5.6 times higher odds of meningioma surgery.
• Short-term use was not linked to a higher risk.
• Some other hormone options, such as the levonorgestrel IUD, showed no excess risk.

The study shows a strong link, not proof that the shot caused any one person’s tumor. The overall chance of developing a meningioma is still low. But for long-term users, the finding helped explain why so many diagnoses raised questions.

“Why didn’t anyone warn me?”

This is one of the most common questions. For most of the years many women were on the shot, the U.S. label did not warn about meningioma.

Here is what changed:

• In 2024, regulators in Europe and Canada added meningioma warnings.
• Also in 2024, the FDA rejected Pfizer’s request to add a U.S. warning, citing limits of the available studies.
• In December 2025, the FDA approved a meningioma warning for the U.S. label, as NBC News reported.

The central claim in the Depo-Provera brain tumor lawsuits is that Pfizer should have warned U.S. patients sooner. Pfizer denies wrongdoing and argues the FDA’s earlier rejection blocks those claims. The court has not made a final ruling on that argument for the cases still being litigated.

Symptoms that were easy to explain away

Meningiomas often grow slowly. Symptoms can appear bit by bit and be blamed on stress, age or migraines. Mayo Clinic lists common symptoms such as:

• Headaches that get worse over time
• Changes in vision
• Hearing loss or ringing in the ears
• Memory problems or trouble finding words
• Seizures
• Weakness in the arms or legs

Many long-term users only learn of a tumor after a scan for something else. Others push for answers after months of symptoms. If you are still having symptoms, our post on symptoms that warrant an MRI may help you talk with your doctor.

Coping with a meningioma diagnosis

Hearing the word “tumor” is hard, even when a meningioma is not cancer. Many people feel shock, anger or guilt. Some women blame themselves for a choice they made with the information they had at the time.

You made a common, approved birth control choice. It is okay to feel upset and to ask hard questions.

Some things that may help:

• Ask your care team to explain your tumor’s size, location and grade.
• Ask what the options are: watching it with scans, surgery or radiation.
• Bring a friend or family member to appointments to help take notes.
• Look for a brain tumor support group, in person or online.
• Talk with a counselor if worry or low mood is affecting daily life.

Questions long-term users ask about claims

Does ten years of use make a claim stronger?

The research links risk to prolonged use, so a long history is often central. But every claim depends on its own facts, including records, diagnosis and treatment. No one can promise an outcome.

What if I cannot remember every clinic?

That is common after a decade. Start with what you remember and request records from each place. Our guide on proving years of Depo-Provera use explains where records live and what to do if some are missing.

What if I stopped years ago?

Stopping does not erase a past history of long-term use. What matters is the full picture: when you used the shot, for how long, and when your tumor was found.

Practical steps to take this month

When you have been on the shot for years, it helps to break the work into small pieces. You do not need to do it all at once.

• Write a rough timeline of where you got each shot, year by year.
• List every name you used during those years.
• Ask your imaging center for copies of your MRI or CT reports.
• Ask your surgeon or oncologist for any pathology report.
• Keep a folder, paper or digital, for every record and letter you receive.
• Note the date you were told about the tumor. State deadlines may depend on it.

If a clinic has closed, write down its name and city anyway. A law firm may know how to track down where old records went.

Where Depo-Provera brain tumor claims stand now

Federal cases are combined in MDL 3140 before Judge M. Casey Rodgers in Florida. The court’s July 27, 2026 order says Pfizer and plaintiff leadership signed a Master Settlement Agreement on July 21, 2026.

The order says the agreement is confidential and covers a majority of federal and New York state court claims. About 80% of current MDL plaintiffs are expected to be eligible. No settlement amounts have been released.

Cases that are not eligible, or that opt out, stay in court. Other state court cases, including a coordinated group in California, continue on their own schedules.

Reading Your Meningioma Report: Terms Behind Depo-Provera Brain Tumor Claims

Your imaging and pathology reports are some of the most important papers in Depo-Provera brain tumor claims. They can also be hard to read. Knowing a few terms can make talks with your doctors, and with a law firm, much easier.

According to the National Cancer Institute, meningioma is the most common type of primary brain tumor. It grows from the meninges, the thin layers that cover the brain and spinal cord.

Tumor grade

Meningiomas are given a grade from 1 to 3 under the World Health Organization system:

• Grade 1. Low-grade and slow-growing. This is the most common type, and it is not cancer.
• Grade 2 (atypical). A middle grade with a higher chance of coming back after treatment.
• Grade 3 (anaplastic). A rare, fast-growing, malignant type.

NCI notes that grade 1 meningiomas are more common in women. Your grade is usually listed on a pathology report after surgery or a biopsy.

Other words you may see

• Intracranial. Inside the skull. Most research on the shot looked at intracranial meningiomas.
• Extra-axial mass. A growth outside the brain tissue itself, a common way radiologists describe a meningioma.
• Mass effect or edema. Pressure or swelling the tumor may cause in nearby brain tissue.
• Resection. Surgery to remove the tumor. A report may say whether removal was complete or partial.
• Active surveillance. Watching the tumor with repeat scans instead of treating it right away.

Ask your doctor to explain anything that is unclear. Then keep a copy of every report. These documents show the diagnosis side of Depo-Provera brain tumor claims, and a firm will usually ask for them first.

How Depo-Provera Brain Tumor Claims Are Reviewed Now

The federal court has set clear rules since the settlement was signed. Case Management Order No. 14, signed on August 10, 2026, explains how cases will move forward.

The registration deadline

The order sets November 30, 2026, as the deadline for claimants to register for the settlement program. If you are a long-term user who has not yet talked with a firm, this date matters. Registration is handled through counsel, so ask early.

What reviewers look for

The settlement terms are confidential. But the court has long required two basic types of proof in these cases:

• Proof that you used Depo-Provera, such as clinic, pharmacy or insurance records
• Proof of a meningioma diagnosis, such as MRI and pathology reports

For long-term users, the first item is often the harder one. Ten years of shots may be spread across several clinics, insurance plans and even last names.

If your case stays in court

Some people are not eligible for the program, choose not to take part, or file later. CMO 14 calls these “litigating plaintiffs.” Their Depo-Provera brain tumor claims must meet tighter steps within 90 days, including a verified fact sheet, proof of use, complete medical records and causation reports from qualified doctors or scientists.

The order says cases that do not comply, and do not fix the problem after a court warning, will be dismissed with prejudice. A participating law firm can explain which group you may fall into.

Talking With Your Doctors and Family

A meningioma diagnosis touches many parts of life. Clear, calm talks with your care team and loved ones can make the months ahead easier, whether or not you pursue a claim.

With your doctors

• Tell each doctor how long you used the shot and when you stopped. The new label asks prescribers to watch for meningioma signs.
• Ask whether you should keep using hormonal birth control, and what options fit your health.
• Ask how often you will need follow-up scans, and get copies of each report.
• If you had surgery, ask for the pathology report and the operative report.

Your doctor’s job is your health, not your legal case. You do not need to discuss Depo-Provera brain tumor claims with your care team. Simply share the facts of your history so they can treat you well.

If you are still on the shot

Some long-term users are still getting injections. Do not stop or skip a dose on your own because of a news story or a claim. Talk with your doctor first about the risks and benefits of each birth control option, and make a plan that protects your health.

If you switch methods, ask the clinic to note the date of your last shot in your chart. That date may matter later.

Reporting a side effect

Patients can report a suspected drug side effect directly to the FDA through its MedWatch program. A report adds to the safety data the agency reviews. It is separate from any lawsuit and does not start a claim.

With your family

Some women feel embarrassed to talk about birth control with relatives. You do not have to share more than you want. It can help to name one trusted person who knows where your records are kept.

If a partner or family member helped with rides, care or household work during treatment, ask them to jot down dates. Notes like these can help show how the diagnosis changed daily life.

Questions to Ask a Law Firm About Depo-Provera Brain Tumor Claims

Going into a first call with a short list of questions can help you feel more in control. A participating law firm may review your history and answer questions like these about Depo-Provera brain tumor claims:

• Which group under the court’s orders am I likely to fall into, and why?
• Will you register my claim before the November 30, 2026 deadline, and how will I know it was done?
• Which of my records are most important, and which ones are still missing?
• How do you handle gaps in my injection history from many years ago?
• Does it matter whether I had surgery, radiation or only scans?
• Who will pay back my health plan, Medicare or Medicaid if there is an award?
• What fees and costs would come out of any recovery, and when are they charged?
• How often will you update me, and who do I call with questions?

Write the answers down, or ask a friend to listen in and take notes. If an answer is unclear, it is fine to ask again.

Red flags to watch for

Be careful with anyone who promises a set dollar amount, pressures you to sign the same day, or asks for money up front to “hold your place.” No one outside the program knows what Depo-Provera brain tumor claims will be paid, because the court describes the terms as confidential.

Protecting your privacy

Your records include personal details about birth control, pregnancy and your health. Ask any firm how it stores and shares your files, and who will see them. Keep your own copies in a safe place, such as a locked drawer or a password-protected folder.

Only share records with people you choose. You can also ask a firm to send all mail and calls to one address or phone number if you want to keep things private at home.

Mistakes That Can Slow Depo-Provera Brain Tumor Claims

Long-term users often have more paperwork to track than others. A few common slip-ups can delay Depo-Provera brain tumor claims or make them harder to review.

• Guessing on dates. Write “about 2012” if you are not sure. Records can confirm the exact dates later.
• Leaving out name changes. Old records may be filed under a maiden or prior married name.
• Skipping smaller clinics. College health centers, family planning clinics and urgent care sites may hold injection records.
• Waiting for every record. You can start a review with what you have. Missing papers can be requested later.
• Believing online “payout” charts. The court describes the settlement as confidential. No official amounts have been released.
• Signing papers you do not understand. Ask questions about fees, costs and releases before you sign.

What the first weeks may look like

After you reach out, a participating law firm may review your history by phone. If it takes the case, it will usually ask you to sign forms so it can request records on your behalf.

Expect some waiting while clinics respond. Under federal privacy rules, providers generally must act on a records request within 30 days, with one possible 30-day extension.

Deadlines vary by state and claim type. Getting organized now can help keep your options open as Depo-Provera brain tumor claims move through the settlement program and the court.

Frequently asked questions

How Direct2Attorney can help

If you got the shot for years and later learned you had a meningioma, you deserve clear answers. Direct2Attorney can connect you with a participating law firm that may review your Depo-Provera brain tumor claim and explain your options. Start on our Depo-Provera lawsuit page.

Direct2Attorney is a legal marketing and referral service, not a law firm. This article is general information, not legal advice. Submitting information does not create an attorney-client relationship.